Literature DB >> 29155287

Challenges to Safe and Effective Pain Management in Patients With Super Obesity: Case Report and Literature Review.

Neha M Kramer1, Halena M Gazelka2, Virginia H Thompson1, John A Batsis3, Keith M Swetz1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29155287      PMCID： PMC6457255          DOI： 10.1016/j.jpainsymman.2017.11.005

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN： 0885-3924            Impact factor:   3.612


× No keyword cloud information.
  23 in total

1.  Trends in Obesity Among Adults in the United States, 2005 to 2014.

Authors:  Katherine M Flegal; Deanna Kruszon-Moran; Margaret D Carroll; Cheryl D Fryar; Cynthia L Ogden
Journal:  JAMA       Date:  2016-06-07       Impact factor: 56.272

Review 2.  Sarcopenic obesity: A Critical appraisal of the current evidence.

Authors:  C M M Prado; J C K Wells; S R Smith; B C M Stephan; M Siervo
Journal:  Clin Nutr       Date:  2012-07-17       Impact factor: 7.324

3.  Application of a systems approach to the bottom-up assessment of pharmacokinetics in obese patients: expected variations in clearance.

Authors:  Cyrus Ghobadi; Trevor N Johnson; Mohsen Aarabi; Lisa M Almond; Aurel Constant Allabi; Karen Rowland-Yeo; Masoud Jamei; Amin Rostami-Hodjegan
Journal:  Clin Pharmacokinet       Date:  2011-12-01       Impact factor: 6.447

4.  Dosing in obesity: a simple solution to a big problem.

Authors:  P Y Han; S B Duffull; C M J Kirkpatrick; B Green
Journal:  Clin Pharmacol Ther       Date:  2007-11       Impact factor: 6.875

5.  Increases in morbid obesity in the USA: 2000-2005.

Authors:  R Sturm
Journal:  Public Health       Date:  2007-03-30       Impact factor: 2.427

6.  Comparative pharmacokinetics of intravenous propranolol in obese and normal volunteers.

Authors:  G Cheymol; J M Poirier; J Barre; A Pradalier; J Dry
Journal:  J Clin Pharmacol       Date:  1987-11       Impact factor: 3.126

7.  Effect of age, gender, and obesity on midazolam kinetics.

Authors:  D J Greenblatt; D R Abernethy; A Locniskar; J S Harmatz; R A Limjuco; R I Shader
Journal:  Anesthesiology       Date:  1984-07       Impact factor: 7.892

8.  Serum protein binding and the role of increased alpha 1-acid glycoprotein in moderately obese male subjects.

Authors:  I H Benedek; R A Blouin; P J McNamara
Journal:  Br J Clin Pharmacol       Date:  1984-12       Impact factor: 4.335

9.  Low Lean Mass With and Without Obesity, and Mortality: Results From the 1999-2004 National Health and Nutrition Examination Survey.

Authors:  John A Batsis; Todd A Mackenzie; Rebecca T Emeny; Francisco Lopez-Jimenez; Stephen J Bartels
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2017-10-01       Impact factor: 6.053
View more
  2 in total

1.  ATHENA: A Phase 3, Open-Label Study Of The Safety And Effectiveness Of Oliceridine (TRV130), A G-Protein Selective Agonist At The µ-Opioid Receptor, In Patients With Moderate To Severe Acute Pain Requiring Parenteral Opioid Therapy.

Authors:  Sergio D Bergese; Marek Brzezinski; Gregory B Hammer; Timothy L Beard; Peter H Pan; Sharon E Mace; Richard D Berkowitz; Kristina Cochrane; Linda Wase; Harold S Minkowitz; Ashraf S Habib
Journal:  J Pain Res       Date:  2019-11-14       Impact factor: 3.133

2.  Somatic Comorbidities and Cardiovascular Safety in Ketamine Use for Treatment-Resistant Depression.

Authors:  Joanna Szarmach; Wiesław Jerzy Cubała; Adam Włodarczyk; Maria Gałuszko-Węgielnik
Journal:  Medicina (Kaunas)       Date:  2021-03-16       Impact factor: 2.430
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.